AJANTA PHARMA LTD.
BSE: 532331
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 1.2K-1.1% | 1.2K+1.0% | 1.2K+19.2% | 1.0K-8.0% | 1.1K-2.4% | 1.1K |
| Other Income | 25.76-65.7% | 75.03+84.7% | 40.63+126.6% | 17.93-46.0% | 33.23-17.6% | 40.34 |
| Total Income | 1.2K-4.9% | 1.3K+3.7% | 1.2K+21.1% | 1.0K-9.1% | 1.1K-2.9% | 1.2K |
| EXPENSES | ||||||
| Expenditure | 909.89-6.5% | 973.30+5.8% | 920.20+14.5% | 803.72+0.1% | 803.00-6.6% | 860.05 |
| Tax | 77.42+6.9% | 72.44-2.1% | 74.02+113.2% | 34.72-56.4% | 79.70+7.4% | 74.22 |
| PROFIT | ||||||
| PBT | 322.46+0.2% | 321.97-2.1% | 328.99+44.2% | 228.15-31.3% | 332.15+7.4% | 309.20 |
| Net Profit | 245.04-1.8% | 249.53-2.1% | 254.97+31.8% | 193.43-23.4% | 252.45+7.4% | 234.98 |
| KEY METRICS | ||||||
| OPM % | 28.26%+4.53pp | 23.73%-3.53pp | 27.26%+2.64pp | 24.62%+0.89pp | 23.73%+2.93pp | 20.80% |
| NPM % | 19.88%+0.62pp | 19.26%-1.15pp | 20.41%+1.66pp | 18.75%-3.49pp | 22.24%+2.14pp | 20.10% |
| EPS | 19.61-1.9% | 19.98-2.1% | 20.41+32.0% | 15.46-23.3% | 20.16+7.5% | 18.75 |
Corporate Events
Board MeetingAJANTPHARM
20253Nov
Board Meeting
Update on board meeting, declaration of interim dividend, fi…
BSE Filing ↗ Board MeetingAJANTPHARM
202428Oct
Board Meeting
Consider and approve unaudited consolidated and standalone f…
BSE Filing ↗ Board MeetingAJANTPHARM
202430Jul
Board Meeting
Consider and approve unaudited consolidated and standalone f…
BSE Filing ↗ Board MeetingAJANTPHARM
20242May
Board Meeting
consider and approve buy-back of Equity Shares and other mat…
BSE Filing ↗ Board MeetingAJANTPHARM
202431Jan
Board Meeting
declaration of 2nd Interim Dividend for the financial year e…
BSE Filing ↗ Board MeetingAJANTPHARM
202331Oct
Board Meeting
Consider and approve Unaudited Consolidated and Standalone F…
BSE Filing ↗